Eugeen Vanmechelen
Gründer bei ADx NeuroSciences NV
Aktive Positionen von Eugeen Vanmechelen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ADx NeuroSciences NV
 ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | - |
| Gründer | 01.01.2011 | - |
Karriereverlauf von Eugeen Vanmechelen
Ausbildung von Eugeen Vanmechelen
| Ghent University | Undergraduate Degree |
Statistik
International
| Belgien | 3 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |
- Börse
- Insiders
- Eugeen Vanmechelen
- Erfahrung
